Facility expansion Tissue Regenix has received confirmation of a $0.3m grant from Universal City to support the commencement of the initial phase of the build out programme on the Company's newly leased 21,000 sq.ft. facility in San Antonio, further details of which were announced on 15 August 2019. This grant will assist and permit the upgrades of utilities and infrastructure serving the new facility. Technical staff necessary to enable the second shift in the original San Antonio facility to become operational have been recruited and are in the process of being trained. Monthly processing throughput has already more than doubled in the year to Q3 and these additional products are expected to become available towards the end of Q4. The Company is working closely with its existing outsource provider, CTS, in order to increase the yield of its DermaPure® product after also announcing the launch of DermaPure® Non-Oriented, for use in surgical and uro-gynaecology applications, at the American Urogynecologic Society conference in Nashville in September. The Company is working closely with its strategic partner, ARMS Medical, on the roll out of this product.
John Samuel, Executive Chairman, Tissue Regenix plc commented, "We have excellent products for which demand is exceeding our current capacity. Therefore, our current focus is ensuring we can increase our capacity to meet this significant demand."